Literature DB >> 18775776

Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage.

Susana Cardoso1, Renato X Santos, Cristina Carvalho, Sónia Correia, Gonçalo C Pereira, Susana S Pereira, Paulo J Oliveira, Maria S Santos, Teresa Proença, Paula I Moreira.   

Abstract

This study was aimed at investigating the effects of subchronic administration of doxorubicin (DOX) on brain mitochondrial bioenergetics and oxidative status. Rats were treated with seven weekly injections of vehicle (sc, saline solution) or DOX (sc, 2 mg kg(-1)), and 1 week after the last administration of the drug the animals were sacrificed and brain mitochondrial fractions were obtained. Several parameters were analyzed: respiratory chain, phosphorylation system, induction of the permeability transition pore (PTP), mitochondrial aconitase activity, lipid peroxidation markers, and nonenzymatic antioxidant defenses. DOX treatment induced an increase in thiobarbituric acid-reactive substances and vitamin E levels and a decrease in reduced glutathione content and aconitase activity. Furthermore, DOX potentiated PTP induced by Ca2+. No statistical differences were observed in the other parameters analyzed. Altogether our results show that DOX treatment increases the susceptibility of brain mitochondria to Ca(2+)-induced PTP opening and oxidative stress, predisposing brain cells to degeneration and death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775776     DOI: 10.1016/j.freeradbiomed.2008.08.008

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  21 in total

1.  Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.

Authors:  Arpit Mehrotra; Abhilasha Sood; Rajat Sandhir
Journal:  Mol Cell Biochem       Date:  2015-09-15       Impact factor: 3.396

2.  Histological experimental study on the effect of stem cell therapy on adriamycin induced chemobrain.

Authors:  Maha Baligh Zickri; Dalia Hussein Abd El Aziz; Hala Gabr Metwally
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

3.  Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries.

Authors:  Sara Emad El-Agamy; Amal Kamal Abdel-Aziz; Sara Wahdan; Ahmed Esmat; Samar S Azab
Journal:  Mol Neurobiol       Date:  2017-10-16       Impact factor: 5.590

4.  Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy.

Authors:  Na Ta; Chuanren Qu; Hao Wu; Di Zhang; Tiantian Sun; Yanjun Li; Jun Wang; Xiaohui Wang; Tieshan Tang; Quan Chen; Lei Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

5.  Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore.

Authors:  Manish Verma; Nataly Shulga; John G Pastorino
Journal:  Biochim Biophys Acta       Date:  2012-10-05

6.  Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus.

Authors:  Mohit Kwatra; Ashok Jangra; Murli Mishra; Yogita Sharma; Sahabuddin Ahmed; Pinaki Ghosh; Vikas Kumar; Divya Vohora; Razia Khanam
Journal:  Neurochem Res       Date:  2016-05-21       Impact factor: 3.996

7.  Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.

Authors:  Noha M Mounier; Sara A Wahdan; Amany M Gad; Samar S Azab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-23       Impact factor: 3.000

8.  Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific.

Authors:  Gonçalo C Pereira; Susana P Pereira; Claudia V Pereira; José A Lumini; José Magalhães; António Ascensão; Maria S Santos; António J Moreno; Paulo J Oliveira
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 9.  Mechanisms of chemotherapy-induced behavioral toxicities.

Authors:  Elisabeth G Vichaya; Gabriel S Chiu; Karen Krukowski; Tamara E Lacourt; Annemieke Kavelaars; Robert Dantzer; Cobi J Heijnen; Adam K Walker
Journal:  Front Neurosci       Date:  2015-04-21       Impact factor: 4.677

10.  Osthole attenuates doxorubicin-induced apoptosis in PC12 cells through inhibition of mitochondrial dysfunction and ROS production.

Authors:  Yalda Shokoohinia; Leila Hosseinzadeh; Maryam Moieni-Arya; Ali Mostafaie; Hamid-Reza Mohammadi-Motlagh
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.